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 ABSTRACT  
     The present study was designed to synthesize  and develop new useful lead compounds (some novel benzazole and 
benzazine derivatives ) of simple structure , exhibiting optimal in vitro anticancer  and antimicrobial potency. 
Phenylenediamine derivative 1 was condensed  with  dithiocarboxylic acid derivatives 2 and produced   benzimidazole 
derivative 4. The benzotriazepines 8 and 10  were formed by the reaction of 1 with dicarbonyl derivatives followed by 
intermolecular coupling reaction. The synthesis of benzotriazine12, benzotriazole 14,17, benzimidazole16 and 
benzothiadiazine 19 from compound 1 was also described. The Synthesized Compounds were characterized by Spectral 
Studies like IR, H
1
 – NMR and Analysis Spectra .The title compounds were screened for their possible In vitro anticancer 
and antimicrobial activities. Among the synthesized compounds, some have shown promisingly remarkable activities 
against  different  cancer cell lines (MCF-7 human breast cancer cells, HepG2 human hepatocarcinoma cells and PC3 
human prostate cancer cells)and moderate  to high antibacterial and antifungal activities. The obtained results showed 
that the most active compounds could be useful as a template for future design, modification and investigation to produce 
more active analogs. 
 Keywords  
Diamine, benzotriazepine, benzotriazole, benzimidazole ,benzothiadiazine , anticancer  and antimicrobial activities . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Council for Innovative Research 
Peer Review Research Publishing System 
Journal: Journal of Advances in Chemistry 
Vol 3, No. 3 
editor@cirworld.com 
www.cirworld.com, member.cirworld.com 
 
ISSN 2321-807X 
253 | P a g e                                                              A u g  2 5 , 2 0 1 3  
1.INTRODUCTION   
Cancer is a broad term used to encompass several malignant diseases. It defined as the uncontrolled and 
undifferentiated growth of abnormal cells that can affect every organ in the body  and sometimes forming excess tissue 
known as tumor. It considered the second leading cause of death following cardiovascular diseases and it is one of the 
most dreadful disease despite the current improved methods of precautions, detections, surgery and therapy hence 
prevention of cancer is still the recognized goal of many activities in cancer research [1].  
In addition, the incidence of fungal and bacterial infections has increased dramatically [2].The widespread use of 
antifungal and antibacterial drugs and their resistance against fungal and bacterial infections has led to serious health 
hazards. The resistance of wide spectrum antifungal and antibacterial agents has initiated discovery and modification of 
the new antifungal and antibacterial agents [3]. 
 On the other hand, Benzazole derivatives were reported as very useful intermediates or subunits of the 
development of pharmaceutical or biological interest [4]. Their application  were recorded in diverse therapeutic areas 
including anti-histaminic [5], anti-inflammatory [6], antiulcer [7], antihypertensive, antiviral, antifungal [8], and anticancer 
[9] activities. On the same ground, benzazine derivatives have attracted considerable interest in their biological activity 
[10] because they are used as antifungal, antimicrobial [11], anti-inflammatory [12] and anticancer agents [13, 14].  
In view of the above observations, the current work was conducted to  synthesize new compounds (some novel 
benzazole and benzazine derivatives ) of pharmacological interest and screen all the synthesized compounds for their 
possible in vitro anticancer and antimicrobial activities as an attempt to find out new biological active compounds in the 
line of anticancer and antimicrobial therapy. 
2.EXPERIMENTAL 
2.1.Chemistry: General 
All melting points are uncorrected and were determined on Gallenkamp electric melting point apparatus. IR spectra 
(KBr discs) were recorded on a FT/IR-400 spectrophotometer (Perkin Elmer). 
1
H-NMR spectra were recorded on a Varian-
300 (DMSO-d6) solution. Chemical shifts were reported as δ values relative to tetramethylsilane (TMS) as internal 
reference. The Analyses were carried out at Micro Analytical Center, Cairo University. 
 
A mixture of compound 1 (0.01 mol), and phenyldithiocarbamic acid   (0.01 mol) in acetic acid (30 ml) was heated 
under reflux for 8 hours. The reaction mixture was cooled, poured into crashed ice and the separated solid product was 
filtered off, dried and crystallized from toluene and gave compound 4a.Yield: 80%; yellow crystals; m.p. 230-232
o
C. IR: 
3562 (NH), 1515 (C=N), 1593 (C=N) cm
-1
 and 
1
H-NMR (DMSO-d6): 7.27-8.35(m, J =8.7 Hz, 8H, Ar-H), 12.39(s, 1H, NH), 
13.2(s, 1H, NH). Anal.: C13H10N4O2 (254.25); Calcd.: C, 61.41; H, 3.96; N, 22.04; Found: C, 61.44; H, 3.99; N, 22.08. 
 4b 
A mixture of 4-nitro-1,2-phenylenediamine 1 (0.01 mol), and 3-oxo-3-phenyldithiopropionic acid (0.01 
mol) in acetic acid (30 ml) was heated under reflux for 10 hours. The reaction mixture was cooled, poured into 
crashed ice  and the separated solid product was filtered off, dried and crystallized from toluene and gave 
compound 4b. Yield: 70%; yellow crystals; m.p. 236-238 
o
C. IR: 3562 (NH), 2922 (aliphatic CH), 1664 (C=O), 
1593 (C=N) cm
-1
 and 
1
H-NMR (DMSO-d6): 2.49(s, 2H, CH2), 7.6-8.35(m, J =8.7 Hz, 10H, Ar-H), 13(s, 1H, 
NH).  Anal.: C15H11N3O3 (281.27); Calcd.: C, 64.05; H, 3.94; N, 14.94; Found: C, 64.01; H, 3.90; N, 14.90. 
 
         A mixture of compound 1 (0.01 mol) and acetylacetone (0.01 mol) in toluene (60 ml) was heated under reflux for 4 
hours. The solid product obtained upon cooling was filtered off, dried and crystallized from benzene and gave compound 
5. Yield: 85%; red crystals; m.p. 170-172
 o
C. IR: 3436 and 3336 (NH2), 1643 (C=O), 1591 (C=N) cm
-1
 and 
1
H-NMR 
(DMSO-d6): 2.49(s, 3H, CH3), 2.5(s, 3H, CH3), 5(s, 2H, NH2),   6(s, 2H, CH2), 7.37-7.42(m, J =8.7 Hz, 3H, Ar-H). Anal.: 
C11H13N3O3 (235.24); Calcd.: C, 56.16; H, 5.57; N, 17.86; Found: C, 56.06; H, 5.52; N, 17.83. 
 7 
A stirred cold solution of compound 5 (0.01 mol) in hydrochloric acid (20 ml) was treated drop wise with a cold 
solution of NaNO2 (0.01 mol) in water (5 ml). The reaction mixture was further stirred for 1 hour, and the separated solid 
product was filtered off, washed with water, dried and crystallized from toluene and gave compound 7. Yield: 85%; white 
crystals; m.p. 224-225 
o
C. IR: 1698 (C=O), 1477 (N=N) cm
-1
   and 
1
H-NMR (DMSO-d6): 2.48(s, 3H, CH3), 2.5(s, 3H, CH3), 
8-8, 32(m, 3H, Ar-H), 8.96(s, 1H, NH). Anal.: C11H10N4O3 (246.23);  Calcd.: C, 53.66; H, 4.09; N, 22.75;  Found: C, 53.69; 
H, 4.06; N, 22.78. 
8  
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 A mixture of compound 1 (0.01 mol) and ethylacetoacetate (0.01 mol) in toluene (60 ml) was heated under reflux 
for 4 hours. The solid product obtained upon cooling was filtered off, dried and crystallized from benzene and gave 
compound 8. Yield: 90%; orange crystals; m.p. 160-162 
o
C. IR: 3348-3436 (NH2), 3197 (NH), 1685 (ketonic C=O), 1643 
(amide C=O) cm
-1
and
 1
H-NMR (DMSO-d6): 2.49(s, 3H, CH3), 5(s, 2H, NH2), 6(s, 2H, CH2), 7.3-8(m, J=3.9 Hz , 3H, Ar-H), 
10.7(s, 1H, NH). Anal.: C10H11N3O4 (237.22); Calcd.: C, 50.63; H, 4.67; N, 17.71; Found: C, 50.60; H, 4.61; N, 17.74. 
10 
   A stirred cold solution of compound 8 (0.01 mol) in hydrochloric acid (20 ml) was treated drop wise with a cold 
solution of NaNO2 (0.01 mol) in water (5 ml). The reaction mixture was further stirred for 1 hour, and the separated solid 
product was filtered off, washed with water, dried and crystallized from benzene and gave  compound 10. Yield: 90%; 
white crystals; m.p. 260-261 
o
C. IR: 1790 (C=O), 3474 (NH), 1481 (N=N) cm
-1 
and 
1
H-NMR (DMSO-d6): 2.5(s, 2H, CH2), 
8-8.32(m, J =10.1 Hz  , 3H, Ar-H), 8.96(s, 1H, NH).Anal.: C8H6N4O3 (206.16); Calcd.: C, 46.61; H, 2.93; N, 27.18; Found: 
C, 46.56 H, 2.88; N, 27.23. 
 
A mixture of compound 1 (0.01 mol) and benzaldehyde (0.01 mol) in absolute ethanol (30 ml) was heated under 
reflux for 4 hours. The solid product obtained upon cooling was filtered off, dried and crystallized from methanol and gave 
compound 11. Yield: 90%; pale   red crystals; m.p. 120-122
o
C. IR: 3326 and 3368 (NH2), 1579 (C=N) cm
-1 
and 
1
H-NMR 
(DMSO-d6): 5 (s, 2H, NH2), 6 (s, 1H, CH=N), 7.37-8.2(m, J =8.7 Hz  ,3H, Ar-H). Anal.: C13H11N3O2 (241.25); Calcd.: C, 
64.72; H, 4.60; N, 17.42; Found: C, 64.77; H, 4.55; N, 17.47. 
12 
 A stirred cold solution of compound 11(0.01 mol) in hydrochloric acid (20 ml) was treated drop wise with a cold 
solution of NaNO2 (0.01 mol) in water (5 ml). The reaction mixture was further stirred for 2 hours, and the separated solid 
product was filtered off, washed with water, dried and crystallized from water and gave  compound 12. Yield: 90%; white 
crystals; m.p. 210-212
o
C. IR: 1527 (C=N), 1488 (N=N) cm
-1
 and 
1
H-NMR (DMSO-d6): 8-8.9(m, 8H, Ar-H). Anal.: 
C13H8N4O2 (252.23); Calcd.: C, 61.90; H, 3.20; N, 22.21; Found: C, 61.85 H, 3.25; N, 22.26. 
   
          A mixture of compound 1 (0.01 mol) and Acetophenone (0.01 mol) in absolute ethanol (30 ml) was heated under 
reflux for 4hours. The solid product obtained upon cooling was filtered off, dried and crystallized from methanol and gave 
compound 13. Yield: 90%; red crystals; m.p. 240-242
o
C. IR: 3379 and 3435 (NH2), 1594 (C=N) cm
-1
 and 
1
H-NMR (DMSO-
d6): 2.49(s, 3H, CH3), 5(s, 2H, NH2),6.5-7.4(m, 8H, Ar-H).Anal.: C14H13N3O2 (255.28); Calcd.: C, 65.87; H, 5.13; N, 16.46; 
Found: C, 65.82; H, 5.16; N, 16.43. 
14 
 A stirred cold solution of compound 13 (0.01 mol) in hydrochloric acid (20 ml) was treated drop wise with a cold 
solution of NaNO2 (0.01 mol) in water (5 ml). The reaction mixture was further stirred for 2 hours, and the separated solid 
product was filtered off, washed with water, dried and crystallized from water and  gave compound 14. Yield: 90%; white 
crystals; m.p. 210
o
C. IR: 1593 (olefinic C=C), 1490 (N=N) cm
-1
and 
1
H-NMR (DMSO-d6): 2.5(s, 2H, CH2), 8-8.9(m, 8H, Ar-
H).Anal.: C14H10N4O2 (266.26); Calcd.: C, 63.15; H, 3.79; N, 21.04; Found: C, 63.18; H, 3.72; N, 21.09. 
15 
A mixture of compound 1 (0.01 mol) and benzoyl isothiocyanate (0.01mole) in dry acetone (20 ml) was heated 
under reflux for 2hours. The solid product obtained during heating was filtered off, dried and crystallized from methanol 
and gave compound 15. Yield: 95%; greenish crystals; m.p. 222-224
 o
C. IR: 3407 and 3318 (NH2), 3217 (NH), 1668 
(C=O), 1256 (C=S) cm
-1
 and 
1
H-NMR (DMSO-d6): 6.5(s, 2H, NH2), 7.4 – 8 (m, J =7.8 Hz , 8H, Ar-H), 8.38(s, 1H, NH), 
13(s, 1H, NH).Anal.: C14H12N4O3S (316.34); Calcd.: C, 53.16; H, 3.82; N, 17.71; Found: C, 53.11; H, 3.87; N, 17.76. 
 
A mixture of compound 15 (0.01 mol) and ethyl cyanoacetate (0.01 mol) in dimethylformaamide (10 ml) was heated 
under reflux for 8hours. The reaction mixture was cooled, poured into crashed ice. The separated solid product was 
filtered off, dried and crystallized from benzene and gave compound 16. Yield: 80%; dark brown crystals; m.p. 260-262 
o
C. 
IR: 3106 (OH), 2215 (CN), 1560 (C=N), 1337 (C=S) cm
-1
 and 
1
HNMR (DMSO-d6): 2.5 (s, 2H, CH2), 7.2 – 8.3(m, 8H, Ar-H), 
12.99(OH). Anal.: C17H11N5O3S (365.37); Calcd.: C, 55.89; H, 3.03; N, 19.17; Found: C, 55.84; H, 3.08 N, 19.22. 
N-(1-(2-(Methyleneamino)-5-nitrophenyl)hydrazinecarbonothioyl)- benzamide  17 
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  A stirred cold solution of compound 15 (0.01 mol) in hydrochloric acid (20 ml) was treated drop wise with a cold 
solution of NaNO2 (0.01 mol) in water (5 ml). The reaction mixture was further stirred for 2 hours, and the reaction mixture 
was diluted with water and the product separated was filtered off, washed with water, dried and crystallized from ethanol 
and gave compound 17. Yield: 90%; brown crystals; m.p. 173-175
o
C. IR: 3367 (OH), 1666 (C=O), 1575 (C=N), 1269 
(C=S) cm
-1 
and 
1
H-NMR (DMSO-d6): 7.4 - 7.8(m, 8H, Ar-H), 8.3(s, 1H, NH), 8.9(s, 1H, OH). Anal.: C15H13N5O3S (343.37); 
Calcd.: C, 52.47; H, 3.82; N, 20.40; Found: C, 52.44; H, 3.85; N, 20.43. 
 
         A mixture of compound 15 (0.01 mol), benzaldhyde and (0.01 mol) in presence of catalytic amount of dimethylamine 
in absolute ethanol (30 ml) was heated under reflux for 3hours. The solid product obtained upon cooling was filtered off, 
dried and crystallized from the methanol and gave compound 18. Yield: 50%; yellow crystals; m.p. 250-253 
o
C. IR: 3345 
(OH), 1505 (C=N), 1317 (C=S) cm
-1 
and 
1
H-NMR (DMSO-d6): 6.4(s, 1H, CH=N), 7.1 – 7.8(m, 13H, Ar-H), 8(s, 1H, NH), 
8.5(s, 1H, OH).Anal.: C21H16N4O3S (365.37); Calcd.: C, 62.36; H, 3.99; N, 13.85; Found: C, 62.31; H, 3.94; N, 13.80. 
 
   A mixture of compound 15 (0.01 mol), iodine (0.01 mol) in acetic acid (20 ml) was heated under reflux for 4hours. 
The solid product obtained upon cooling was filtered off, dried and crystallized from ethanol and gave compound 19. Yield: 
80%; pink crystals; m.p. 270-273
o
C. IR: 3442 (NH), 1663 (C=O), 1560 (C=N) cm
-1
. 
1
H-NMR (DMSO-d6): 7.2-8.5(m, 8H, Ar-
H), 13(s, 1H, NH), 13.17(s, 1H, NH). Anal.: C14H10N4O3S (314.32); Calcd.: C, 53.50; H, 3.21; N, 17.82; Found: C, 53.53; H, 
3.24 N, 17.79. 
2.2.Anticancer activity evaluation (Cytotoxicity Assessment ) : 
2.2.1.Cell culture: 
      MCF-7 human breast cancer cells & HepG2 human hepatocarcinoma cells and      PC3 human prostate cancer cells 
were purchased from the Egyptian Holding Company for Biological Products & Vaccines (VACSERA), Giza, Egypt, and 
then maintained in the tissue culture unit  (Faculty of Pharmacy, Ain Shams University, Cairo, Egypt). The cells were 
grown in RPMI-1640 medium, supplemented with 10% heat inactivated FBS, 50 units/mL of penicillin and 50 mg/mL of 
streptomycin and maintained at 37° in a humidified atmosphere containing 5% CO2. The cells were maintained as 
“monolayer culture” by serial subculturing. Cell culture reagents were obtained from Lonza (Basel, Switzerland). 
2.2.2.SRB cytotoxicity assay: 
Cytotoxicity was determined using SRB method as previously described by Skehan et al. [15]. Exponentially 
growing cells were collected using 0.25% Trypsin-EDTA and seeded in 96-well plates at 1000-2000 cells/well in RPMI-
1640 supplemented medium. After 24 h, cells were incubated for 72 h with various concentrations of the tested 
compounds. Following 72 h treatment, the cells will be fixed with 10% trichloroacetic acid for 1 h at 4 ºC. Wells were 
stained for 10 min at room temperature with 0.4% SRB (Sulphorhodamine B )dissolved in 1% acetic acid. The plates were 
air dried for 24 h and the dye was solubilized with Tris-HCl for 5 min on a shaker at 1600 rpm. The optical density (OD) of 
each well was measured spectrophotometrically at 564 nm with an ELISA microplate reader (ChroMate-4300, FL, USA). 
The IC50 values were calculated according to the equation for Boltzman sigmoidal concentration–response curve using the 
nonlinear regression fitting models (Graph Pad, Prism Version 5). 
2.3. Antimicrobial activity evaluation : 
Antimicrobial activity of the tested compounds  was determined using a modified Kirby-Bauer disc diffusion 
method  [16]. Briefly, 100 µl of the test bacteria/fungi were grown in 10 ml of fresh media until they reached a count of 
approximately 108 cells/ml for bacteria or 105 cells/ml for fungi [17]. 100 µl of microbial suspension was spread onto agar 
plates corresponding to the broth in which they were maintained.Isolated colonies of each organism that might be playing 
a pathogenic role should be selected from primary agar plates and tested for susceptibility by disc diffusion method 
[18,19]. 
Of the many media available, NCCLS recommends Mueller-Hinton agar due to: it results in good batch-to-batch 
reproducibility. Disc diffusion method for filamentous fungi tested by using approved standard method (M38-A) developed 
by the [20] for evaluating the susceptibilities of filamentous fungi to antifungal agents.Disc diffusion method for yeasts 
developed by using approved standard method (M44-P) by the [21]. 
Plates inoculated with filamentous fungi as Aspergillus flavus at 25
o
C for 48 hours; Gram (+) bacteria as 
Staphylococcus aureus, Bacillus subtilis; Gram (-) bacteria as Escherichia coli, Pseudomonas aeuroginosa they 
were incubated at 35-37
o
C for 24-48 hours and yeast as Candida albicans incubated at 30
o
C for 24-48 hours and, then 
the diameters of the inhibition zones were measured in millimeters [16]. 
Standard discs of Tetracycline (Antibacterial agent), Amphotericin B (Antifungal agent) served as positive 
controls for antimicrobial activity but  filter discs impregnated with 10 µl of solvent (distilled water, chloroform, DMSO) were 
used as a negative control.  
The agar used is Meuller-Hinton agar that is rigorously tested for composition and pH. Further the depth of the 
agar in the plate is a factor to be considered in the disc diffusion method. This method is well documented and standard 
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zones of inhibition have been determined for susceptible and resistant values.Blank paper disks (Schleicher & Schuell, 
Spain) with a diameter of 8.0 mm were impregnated 10µ of tested concentration of the stock solutions.  
When a filter paper disc impregnated with a tested chemical is placed on agar the chemical will diffuse from the 
disc into the agar. This diffusion will place the chemical in the agar only around the disc. The solubility of the chemical and 
its molecular size will determine the size of the area of chemical infiltration around the disc. If an organism is placed on the 
agar it will not grow in the area around the disc if it is susceptible to the chemical. This area of no growth around the disc is 
known as a “Zone of inhibition” or" Clear zone".For the disc diffusion, the zone diameters were measured with slipping 
calipers of the National Committee for Clinical Laboratory Standards  [18]. 
Agar-based methods such as Etest and disk diffusion can be good alternatives because they are simpler and 
faster than broth-based methods [22,23]. 
3.RESULTS and Discussion 
3.1.Chemistry 
       O-phenylenediamine seemed of suitable located functionally for further heterocyclization giving benzazoles and 
benzazines, thus the fusion of imidazole to benzene ring was achieved by one pot procedure via refluxing  o-
phenylenediamine  derivative and  dithiocarboxylic acid derivatives. 
O
2
N NH
2
NH
2
S
SH
AcOH
N
N
X
O
2
N
H
CX
O
2
N NH-C-X
NH
2
S
 
O
+
1                                        2                                                   3              
4
a, X = -NH-Ph ;  b, X = -CH
2
C-Ph  
The reaction may be proceeded   via the condensation reaction between the more basic amino group gave the 
nonisolable acyclic thioamide derivative followed by the intramolecular cyclocondensation via loosing H2S and gave the 
final product 4. The IR spectrum of compound 4a showed absorption bands at  3562 (NH), 1515 (C=N) cm
-1
  and The 
1
HNMR spectrum of compound 4a showed signals at δ 12.39 ppm and δ 13.2 ppm  characteristic for 2NH. The IR 
spectrum of compound 4b showed absorption bands at  3562 (NH), 1664 (C=O) cm
-1
 and The 
1
HNMR spectrum of 
compound 4b showed signals at δ 2.49 ppm characteristic for CH2 and at δ 13 ppm characteristic for NH.   
The synthetic strategy toward the desired  benzotriazepines depended on the condensation of o-phenylenediamine 
derivative 1 with dicarbonyl compound followed by diazotization and subsequent intramolecular coupling afforded the final 
benzazepine compounds.Thus condensation of compound 1 and acetylacetone  gave the enaminic product 5 that undergo 
intramolecular heterocyclization via diazotization through the coupling of electrophilic nitrogen to the nucleophilic carbon 
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and gave benzotriazepine 7 and none of the expected  triazole 6  was obtained.  (Scheme1) 
O
2
N NH
2
NH
2
O O
CH
3 C C CH3
ON
NH
2
O
2
N
N
N
NO2N
CH
3
O
CH
3
N
H
N N
O
2
N
CH
3
O
CH
3
NaNO
2
 / HCl
+
toluene
1                                                                                                5
=
6                                               7
Scheme 1  
 
The formation of 7 is potentiated by the absence of enaminic proton in
1
HNMR spectrum. 
The IR spectrum of compound 5 showed absorption bands at  3436 and 3336 (NH2), 1643 (C=O) cm
-1
  and The 
1
H-NMR 
spectrum of compound 5 showed signals at δ 2.49 and 2.5 ppm characteristic for 2CH3 groups and at δ 6 ppm 
characteristic for CH2. The IR spectrum of compound 7 showed absorption bands 1698 (C=O)cm
-1
 and The 
1
H-NMR 
spectrum of compound 7 showed signals at δ 2.48 and 2.5 ppm characteristic for 2CH3 groups and at δ 8.96 ppm 
characteristic for NH. Refluxing of phenylenediamine derivative 1 and ethyl acetoacetate resulted in the thermodynamic 
condensation product afforded acetoacetanilide derivative 8. Diazotization of compound 8 yielded benzotriazepine 10 
presumably via the nonisolable benzotriazepine 9 that undergo spontaneous ketonic hydrolysis afforded compound 10. 
(Scheme 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The IR spectrum of compound 8 showed absorption bands at 1685 (ketonic C=O), 1643 (amide C=O) cm
-1
and The 
1
HNMR Spectrum of compound 8 showed signals at δ 2.49 ppm characteristic for CH3 group and δ 6 ppm characteristic 
for CH2. The IR spectrum of compound 10 showed absorption bands at 1790 (C=O), 3474 (NH) cm
-1 
and The 
1
HNMR 
spectrum of compound 10 showed signals at δ 2.5 ppm characteristic for characteristic for CH2. 
 Condensation of diamine derivative 1 and benzaldhyde afforded shiff base 11, That undergo intramolecular 
cyclization via reaction with nitrous acid produced   benzotriazine 12. (Scheme 3) 
O
2
N NH
2
NH
2
CH
3
O O
OEt
N
H
OO
NH
2
O
2
N
NaNO
2
 / HCl
N
H
N
N
O
O
2
N N
H
N
N
O
O
2
N
CH
3
O
 
toluene
+
1                                                                                           8
Ketonic
hydrolysis
                                                                               9
Scheme 2
10
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The IR spectrum of compound 11 showed absorption bands at 3326 and 3368 (NH2), 1579 (C=N) cm
-1 
 and The 
1
HNMR 
spectrum of compound 11 showed signals at δ 6 ppm characteristic for CH=N. The IR spectrum of compound 12 showed 
absorption bands at 1527 (C=N), 1488 (N=N) cm
-1 
 and The 
1
H-NMR spectrum of compound  12 showed signals at δ 8-8.9 
ppm characteristic for Ar-H. 
   The amino compound 1 formed condensation product 13 with acetophenone. Compound 13 undergo intramolecular 
cyclization via reaction with nitrous acid gave benzotriazole as final product 14 according to scheme 4.  
 
O
2
N NH
2
NH
2
CO
CH
3
Ph
O
2
N N
NH
2
Ph
CH
3
NaNO
2
 / HCl
N
N
NO
2
N
Ph
+
1                                                                                13
14
Scheme 4  
 
   The IR spectrum of compound 13 showed absorption bands at   3379 and 3435 (NH2), 1594 (C=N) cm
-1 
  and 
The 
1
HNMR spectrum of compound 13 showed signal at δ 2.49 ppm characteristic for CH3.The IR spectrum of compound 
14 showed absorption bands at 1593 (olefinic C=C), 1490 (N=N) cm
-1 
and The 
1
H-NMR spectrum of compound 14 showed 
signal at δ 2.5 ppm characteristic for CH2. 
The amino compound 1 was added to the electrophilic carbon of isothiocyanate group of benzoylisothiocyanate   
produced thiourea derivative 15 . The IR spectrum of compound 15 showed absorption bands at  1668 (C=O), 1256 (C=S) 
cm
-1 
 and The 
1
H-NMR spectrum of compound  15 showed signals at δ 8.38 ppm and δ 13 ppm characteristic for 2NH 
groups. Compound 15 undergo further heterocyclization and functionalization, thus when thiourea derivative 15 refluxed 
with ethylcyanoacetate produced benzimidazole derivative 16 . The IR spectrum of compound 16 showed absorption 
O
2
N
NH
2
NH
2
Ph-C-H
O
O
2
N
NH
2
N Ph
NaNO
2
 / HCl
N
N
NO
2
N Ph
+
1                                                                              11
12Scheme 3
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bands at  3106 (OH), 2215 (CN), 1560 (C=N) cm
-1 
 and The 
1
H-NMR spectrum of compound  16 showed signals at δ 2.5 
ppm characteristic for CH2 and δ 12.99 ppm characteristic for OH group. 
Diazotization of compound 15 afforded benzotriazole derivative 17. The IR spectrum of compound 17 showed 
absorption bands at  3367 (OH), 1666 (C=O)cm
-1 
 and The 
1
H-NMR spectrum of compound  17 showed signals at δ 
8.3ppm characteristic for NH and δ 8.9 ppm characteristic for OH. 
Shiff base 18 was obtained via condensation of 15 with benzaldhyde. The IR spectrum of compound 18 showed 
absorption bands at  3345 (OH), 1505 (C=N)cm
-1 
 and The 
1
H-NMR spectrum of compound  18 showed signal at δ 6.4 
ppm characteristic for CH=N and δ 8.5 ppm characteristic for OH group. (Scheme 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oxidative cyclization of thiourea derivative 15 was achieved by refluxing compound 15 and iodine in acetic acid 
produced benzothiadiazine derivative 19 not the expected benzothiazole derivative 20. The IR spectrum of compound 19 
showed absorption bands 3442 (NH), 1663 (C=O) cm
-1 
 and The 
1
H-NMR spectrum of compound  19 showed signals at δ 
13 ppm and δ 13.17 ppm characteristic for 2NH   . (Scheme 6) 
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3.2. Anticancer  activity : 
 All the synthesized compounds were tested for In vitro anticancer activity using SRB cytotoxicity assay method. 
The anticancer screening of the tested compounds revealed that, all the synthesized compounds exhibited non significant 
cytotoxic activity against  MCF-7 human breast cancer cells & Hep G2 human hepatocarcinoma cells  and  PC3 human 
prostate cancer cells  lines except for compounds 19,16,14 which showed potent inhibitory effect on the examined cell 
lines ( Table 1 & Figures 1,2,3).  
 From table (1) , we can notice that compound 16 exhibited the most potent anticancer activity on MCF-7 human 
breast cancer cells by IC50 (1.513 µM)  while  on  Hep G2 human hepatocarcinoma cells  and PC3 human prostate 
cancer cells   compound 19 exhibited the maximum cytotoxic activity  by IC50 (1.952 and 2.36  µM ) respectively.   
Table (1) : Anticancer activity of the target compounds against different cell lines 
 
Compound 
IC50  ( µM ) 
MCF-7 human breast cancer 
cells 
Hep G2 human hepatocarcinoma 
cells 
PC3 human prostate cancer 
cells    
19 3.539 1.952 2.36   
16 1.513 2.405 3.657   
14 75.36 113.3 398.0 
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   IC50= 3.539 µM                             IC50= 1.513 µM                                  IC50= 75.36 µM 
Fig.1 : Anticancer activity of the target compounds against MCF-7 human breast cancer cells 
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Fig.2 : Anticancer activity of the target compounds against Hep G2 human hepatocarcinoma cells 
Cpd 19                                         Cpd 16                                           Cpd 14 
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IC50= 2.36  µM                              IC50= 3.657  µM                               IC50 = 398.0 µM 
Fig.3 : Anticancer activity of the target compounds against PC3 human prostate cancer cells 
3.3. Antimicrobial  activity : 
Antimicrobial activity of the tested compounds  was examined  using a modified Kirby-Bauer disc diffusion 
method and the inhibition zones caused by the various compounds on the microorganisms were determined. The results 
of the  Antibacterial assay of all the titled compounds showed good activities against both Gram positive and Gram 
negative bacterial models. These activities were ranged from moderate to high  and the most potent activities were 
belonged to compounds 14 and 5 compared with the activity of the standard antibacterial drug (tetracycline). The activity 
data generated are tabulated in Table 2. 
From the data obtained in Table 2, it is also clear that all the tested compounds were found to be inactive against 
Aspergillus flavus while they exhibited moderate activity against Candida  albicans compared with that of the standard 
antifungal drug (Amphotericin B) and the best results was belonged to compound 19. 
Table 2. Antimicrobial activity of the tested compounds 
Candida  
albicans  
(Yeast) 
Aspergillus 
        flavus 
(Fungus) 
Pseudomonas  
    aeruginosa 
(G
-
) 
Escherichia  
            coli 
(G
-
) 
Staphylococcus 
       aureus  
(G
+
) 
Bacillus 
subtilis 
(G
+
) 
Sample 
-- -- 30 31 28 30 
Tetracycline 
Antibacterial 
agent 
S
ta
n
d
a
rd
 
19 17 -- -- -- -- 
Amphotericin B 
Antifungal 
agent 
0.0 0.0 0.0 0.0 0.0 0.0 Control: DMSO 
9 0.0 10 9 11 9 4b 
10 0.0 15 13 15 13 17 
11 0.0 9 9 13 9 19 
9 0.0 11 11 14 10 4a 
9 0.0 11 11 9 10 16 
9 0.0 27 25 27 25 14 
10 0.0 25 25 24 21 5 
0.0 0.0 15 15 10 13 7 
0.0 0.0 13 20 22 18 10 
 
Note: ‘-‘denotes no activity, 6-8 mm poor activity, 9-11 mm moderate activity, > 12 mm potent activity. 
In the frame of our results , it is true and fitting to mention that earlier studies supported our findings . [24] 
reported that, some novel benzothiadiazine drevatives showed significant growth inhibitory activity against selected human 
tumor cell lines. Interestinlgy, one of the synthesized benzothiadiazine drevatives, exhibited GI50 values of 1.4 and 2.1 μM 
against RPMI-8226 (leukemia) and HOP-62 (lungs) cell lines, respectively. The sulfamido moiety in the main heterocycle 
is crucial for cytotoxicity [25].In addition, it is documented previously that some modified  benzothiadiazine drevatives 
exhibited remarkable potent inhibitory activity  against many bacterial species in comparison to the standard drugs [26].  
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In keeping with this line, Benzimidazoles were reported to posses anticancer activity.They  are potent anti-tumor, 
and anti-parasitic agents, whose mode of action is thought to result from their inhibition of microtubule  ; the elements of 
spindle ; formation and  functions that results in antimitotic effect [27].   
  Similarly, It was proved that , benzotriazole drevatives posses various biological activities including antimicrobial 
ad anticancer activities [28]and it  has  in vitro cytotoxic activity against human cancer cell lines including lung carcinoma 
(A549), cervix epithelial carcinoma (HeLa), osteosarcoma (HOS), malignant melanoma (G361), breast adenocarcinoma 
(MCF7), ovarian carcinoma (A2780) and cisplatin-resistant ovarian carcinoma (A2780cis) [29]. 
4.CONCLUSION 
From the obtained results we can conclude that, benzothiadiazine derevative ( cpd 19) & benzimidazole  
drevative ( cpd 16 ) and benzotriazole ( cpd 14)  elicited the most potent  cytotoxic effect on the tested cancer cell lines 
while, cpds 14 and 5 were the most active cpds against both gram +ve and gram-ve bacterial infection however cpd 19 
was the best against fungal infection . These compounds could therefore serve as a lead promising molecules for further 
modification to obtain clinically useful  anticancer and antibacterial agents. 
 In general ,The present study throws light on the identification of this new structural class as  anticancer and 
antimicrobial agents which can be of interest for further detailed preclinical investigations 
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